Kovo Healthtech Corp (KOVO) - Net Assets

Latest as of September 2025: CA$-7.53 Million CAD ≈ $-5.45 Million USD

Based on the latest financial reports, Kovo Healthtech Corp (KOVO) has net assets worth CA$-7.53 Million CAD (≈ $-5.45 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$14.72 Million ≈ $10.65 Million USD) and total liabilities (CA$22.25 Million ≈ $16.10 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read KOVO current and long-term liabilities for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CA$-7.53 Million
% of Total Assets	-51.18%
Annual Growth Rate	N/A
5-Year Change	N/A
10-Year Change	N/A
Growth Volatility	N/A

Kovo Healthtech Corp - Net Assets Trend (2020–2024)

This chart illustrates how Kovo Healthtech Corp's net assets have evolved over time, based on quarterly financial data. Also explore how large is Kovo Healthtech Corp's balance sheet for the complete picture of this company's asset base.

Annual Net Assets for Kovo Healthtech Corp (2020–2024)

The table below shows the annual net assets of Kovo Healthtech Corp from 2020 to 2024. For live valuation and market cap data, see Kovo Healthtech Corp market cap and net worth.

Year	Net Assets	Change
2024-12-31	CA$-3.99 Million ≈ $-2.89 Million	-1235.79%
2023-12-31	CA$-299.00K ≈ $-216.29K	-132.36%
2022-12-31	CA$924.00K ≈ $668.41K	+643.53%
2021-12-31	CA$-170.00K ≈ $-122.98K	+72.31%
2020-12-31	CA$-614.00K ≈ $-444.16K	--

Equity Component Analysis

This analysis shows how different components contribute to Kovo Healthtech Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 1350100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Other Components	CA$12.82 Million	%
Total Equity	CA$-3.99 Million	100.00%

Kovo Healthtech Corp Competitors by Market Cap

The table below lists competitors of Kovo Healthtech Corp ranked by their market capitalization.

Company	Market Cap
CNS Pharmaceuticals Inc NASDAQ:CNSP	$1.77 Million
ZAZZ Energy of Sweden AB ST:ZAZZ-B	$1.77 Million
Propell Holdings Ltd AU:PHL	$1.77 Million
Kore Potash Plc LSE:KP2	$1.77 Million
China SXT Pharmaceuticals Inc NASDAQ:SXTC	$1.77 Million
MJ Gleeson plc LSE:GLE	$1.76 Million
ActiveOps PLC LSE:AOM	$1.76 Million
KEFI Gold and Copper Plc LSE:KEFI	$1.76 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Kovo Healthtech Corp's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from -299,000 to -3,994,000, a change of -3,695,000.
Net loss of 5,867,000 reduced equity.
Other factors increased equity by 2,172,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CA$-5.87 Million	-146.9%
Other Changes	CA$2.17 Million	+54.38%
Total Change	CA$-	%

Book Value vs Market Value Analysis

This analysis compares Kovo Healthtech Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2020-12-31	CA$-0.02	CA$0.02	x
2021-12-31	CA$0.00	CA$0.02	x
2022-12-31	CA$0.02	CA$0.02	x
2023-12-31	CA$-0.01	CA$0.02	x
2024-12-31	CA$-0.03	CA$0.02	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Kovo Healthtech Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.00%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -55.55%
• Asset Turnover: 0.93x
• Equity Multiplier: 0.00x
Recent ROE (0.00%) is above the historical average (-5.41%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2020	0.00%	-39.72%	0.95x	0.00x	CA$-1.14 Million
2021	0.00%	-45.73%	0.81x	0.00x	CA$-2.68 Million
2022	-27.06%	-2.30%	1.57x	7.50x	CA$-342.40K
2023	0.00%	-46.77%	1.08x	0.00x	CA$-4.65 Million
2024	0.00%	-55.55%	0.93x	0.00x	CA$-5.47 Million

Industry Comparison

This section compares Kovo Healthtech Corp's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

Industry: Health Information Services
Average net assets among peers: $342,089
Average return on equity (ROE) among peers: -114.29%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Kovo Healthtech Corp (KOVO)	CA$-7.53 Million	0.00%	N/A	$1.77 Million
Diagnos Inc (ADK)	$-113.51K	0.00%	0.00x	$16.95 Million
Comprehensive Healthcare Systems Inc (CHS)	$602.59K	-817.41%	5.81x	$8.96 Million
Carespan Health Inc (CSPN)	$-699.52K	0.00%	0.00x	$688.89K
CardioComm Solutions Inc. (EKG)	$-423.38K	0.00%	0.00x	$1.43 Million
Kneat.com Inc (KSI)	$-1.55K	0.00%	0.00x	$309.65 Million
Newtopia Inc (NEWU)	$-1.84 Million	0.00%	0.00x	$626.69K
NexgenRX Inc. (NXG)	$1.84 Million	-11.30%	10.51x	$19.03 Million
Principal Technologies Inc (PTEC)	$939.12K	-171.97%	0.61x	$19.20 Million
Reliq Health Technologies Inc (RHT)	$2.78 Million	-27.94%	0.04x	$30.60 Million

About Kovo Healthtech Corp

V:KOVO Canada Health Information Services

Market Cap

$1.92 Million

CA$2.65 Million CAD

Market Cap Rank

#29804 Global

#1514 in Canada

Share Price

CA$0.02

Change (1 day)

+0.00%

52-Week Range

CA$0.01 - CA$0.07

All Time High

CA$1.03